SantaCruz K S, Tasaki C S, Kim R C, Cotman C W
Department of Pathology, University of Kansas Medical Center, Kansas City, KS 66160-7410, USA.
J Alzheimers Dis. 2002 Feb;4(1):11-7. doi: 10.3233/jad-2002-4102.
In order to study the clinical overlap between neuropathologically defined Lewy body disease (LBD) and Alzheimer's disease, we examined the brains of 37 demented and 13 non-demented subjects. Nigral Lewy bodies (LBs) were present in 16/37 dementia patients, 13 of which had LBD. Eight of these 13 were clinically indistinguishable from AD patients, and in these cases isocortical neurofibrillary tangle (NFT) formation was rare. Thus, although the two conditions were clinically similar in this series, LBD could be distinguished from AD pathologically not only by the presence of nigral LBs but also by the relative paucity of isocortical NFTs.
为了研究神经病理学定义的路易体病(LBD)与阿尔茨海默病之间的临床重叠情况,我们检查了37名痴呆患者和13名非痴呆受试者的大脑。37名痴呆患者中有16名存在黑质路易体(LB),其中13名患有LBD。这13名患者中有8名在临床上与AD患者无法区分,在这些病例中,等皮质神经原纤维缠结(NFT)形成罕见。因此,尽管在该系列中这两种疾病在临床上相似,但LBD不仅可通过黑质LB的存在,还可通过等皮质NFT相对较少在病理上与AD区分开来。